PETMED EXPRESS INC
PETSNASDAQTrading Snapshot
- Day Range
- $1.39 – $1.42
- 52-Week Range
- $1.38 – $4.10
- Volume
- $2.79B
- Avg Volume
- $3.13B
- Shares Outstanding
- 21.4M
- Next Earnings
- Nov 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $179M
- Last Q Revenue
- $41M
- P/E Ratio
- -1.0
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-1.35
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.2%
Why Investors Own PETS
- ✓High-growth profile — revenue up +12.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 74% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PETMED EXPRESS INC
PETS
StockOtter · stockotter.spaceAbout PETMED EXPRESS INC
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Hum
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement
PetMeds Appoints Andrew Parry as Chief Technology Officer
DELRAY BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Andrew Parry as Chief Technology Officer, effect
Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)
Carvana (NYSE: CVNA - Get Free Report) and PetMed Express (NASDAQ: PETS - Get Free Report) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the stre
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates
PetMed (PETS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of $0.12. This compares to a loss of $0.34 per share a year ago.